Fludarabine
Acute Undifferentiated Leukemia
Fred Hutchinson Cancer CenterSmall moleculePhase 2Active
BB
71/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 60/ 100
- Competitive Position
- 89/ 100
Competitive context
32 Active assets in the Acute Undifferentiated Leukemia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cyclophosphamide Masonic Cancer Center, University of Minnesota | Phase 3 | BB |
Dexasone Therapeutic Advances in Childhood Leukemia Consortium | Phase 3 | BB |
Methotrexate Therapeutic Advances in Childhood Leukemia Consortium | Phase 3 | BB |
Vincristine Sulfate M.D. Anderson Cancer Center | Phase 3 | BB |
Cytarabine Fred Hutchinson Cancer Center | Phase 3 | BB |
View all 50 →
Same molecule, other indications
Fludarabine is also rated in:
acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative · Phase 2
76 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →